[1]
Romozzi, M., Burgalassi, A., Vollono, C., Albanese, M., Vigani, G., De Cesaris, F., Chiarugi, A., Calabresi, P. and Iannone, L.F. 2024. Prospective evaluation of aura during anti-calcitonin gene-related peptide monoclonal antibody therapy after 52 weeks of treatment. Confinia Cephalalgica. 34, 1 (May 2024). DOI:https://doi.org/10.4081/cc.2024.15762.